Published trade mark details for 2601336

This information was published on 2026-01-27T08:52:39 for IP Right Registration Published.

Field Value
(210) 2601336 (IR 1884883)
(220) 07 Oct 2025
(300) US, 07 May 2025, 99173108
(511) (510) Class 44
Medical screening; medical testing for diagnostic or treatment purposes; DNA screening for medical purposes.
(540) NEURODEVELOPMENTNEXT
(550) Word
(730) Ambry Genetics Corporation

 

Find out more about publications on the About page.